RONALD STEIN: Open Payments
NPI 1326225533 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 9 payments from 6 companies in 2025. Trend: 2023 $1,477 · 2024 $188 · 2025 $1,202
Consulting: $732Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 2 | $795 |
| Incyte Corporation | 3 | $180 |
| Astellas Pharma US Inc | 1 | $135 |
| SOBI, INC | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
Products named: ZIIHERA, ZYNYZ, Vyloy, Doptelet, ENHERTU, Fabhalta, MONJUVI.
Industry payments across CA — which companies pay providers there.
